Archives
-
Pregnancy-Directed mRNA Delivery: LNP Structure and Safety
2026-08-18
This PNAS study shows that lipid nanoparticle structure and administration route jointly determine mRNA expression, inflammatory responses, and maternal–fetal outcomes during pregnancy. Its comparative design provides a practical framework for evaluating potency and safety together rather than treating delivery efficiency as an isolated endpoint.
-
HyperScript III RT SuperMix for CRC qPCR
2026-08-18
Use HyperScript III RT SuperMix to convert challenging colorectal cancer RNA into reproducible cDNA for biomarker validation, with integrated genomic DNA contamination removal. The workflow is especially suited to low-input, high-GC, and low-copy targets such as CLCA1, UGT2A3, and ZG16.
-
EZ Cap™ Firefly Luciferase mRNA Workflow Guide
2026-08-17
Build sensitive mRNA delivery, translation, viability, and imaging workflows with a Cap1- and poly(A)-optimized firefly luciferase reporter. Practical handling, assay design, and troubleshooting guidance helps distinguish delivery failure from transcript instability, substrate variation, or cell-state effects.
-
CAY10499: HSL Inhibitor for Lipid Assays
2026-08-17
CAY10499 enables controlled interrogation of HSL, MGL, and related lipid-hydrolysis pathways in biochemical, cellular, and immunometabolic workflows. This guide connects practical lipase assay design with extracellular-vesicle-driven macrophage research while clearly separating established product performance from application-level recommendations.
-
Resiquimod (R-848) Workflows for Immune Activation
2026-08-16
Resiquimod (R-848) provides a practical way to interrogate TLR7/8-driven innate signaling in cell, vaccine, and tumor-ablation models. This guide connects stock preparation and cytokine assays with a thermal-protective hydrogel workflow, while emphasizing controls, interpretation, and troubleshooting.
-
Tamsulosin for Preventing Postoperative Urinary Retention
2026-08-15
This systematic review and meta-analysis synthesized 23 randomized controlled trials to evaluate whether perioperative Tamsulosin reduces postoperative urinary retention (POUR). Across 22 quantitatively analyzed studies, Tamsulosin halved POUR risk and improved maximum urinary flow rate, while showing no significant effect on surgery duration, symptom scores, quality of life, or urinary tract infection incidence.
-
From ΔΨm to Translation: Making Apoptosis Measurable
2026-08-14
Mitochondrial membrane potential is more than a fluorescent endpoint: it is a functional bridge between mechanism, treatment response, and translational decision-making. This thought-leadership article connects the hypoxia-activated BNNC photomolecular glue study with practical assay strategy, showing how the JC-1 Mitochondrial Membrane Potential Assay Kit can strengthen apoptosis assay design, mitochondrial function analysis, and oncology development workflows.
-
A-1155463: Mapping BCL-XL Dependence
2026-08-14
BCL-XL inhibitor A-1155463 provides a selective way to test mitochondrial apoptotic dependence in cancer models. This article connects its pharmacology with a glioblastoma study to develop a dependency-aware framework for assay design, interpretation, and translational research.
-
CAY10499: Inhibitor of Human Hormone Sensitive Lipase
2026-08-13
CAY10499 enables controlled interrogation of HSL-, MGL-, FAAH-, and endocannabinoid-linked lipid flux in biochemical and cellular assays. Its value is complementary to ACLY-centered tumor-macrophage studies: it helps determine whether downstream fatty-acid mobilization or 2-arachidonoylglycerol turnover contributes to an observed phenotype.
-
Dextran sulfate sodium salt in IBD workflows
2026-08-13
Build reproducible intestinal inflammation studies with DSS (MW 35000-45000), from controlled epithelial injury to repair-focused molecular assays. This workflow connects colitis severity measurements with the GPR35-KLF5 repair circuitry highlighted in recent ulcerative colitis research.
-
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer
2026-08-12
This FASEB Journal study developed chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. The work links restored nuclear p21 expression to cell-cycle inhibition, DNA-damage signaling, apoptosis, and tumor suppression, while demonstrating bladder-focused delivery with limited transient systemic distribution in mice.
-
Azithromycin and Roxithromycin as Senolytics
2026-08-12
Ozsvari and colleagues identified azithromycin and roxithromycin as clinically approved macrolides that preferentially eliminate DNA-damage-induced senescent human fibroblasts. Their screening and validation strategy connects senolytic selectivity with altered glycolysis, autophagy, and mitochondrial respiration while also showing that closely related erythromycin lacks the same activity.
-
JNJ-26854165: Practical Cancer Assay Workflows
2026-08-11
Learn how to use JNJ-26854165 (Serdemetan) to connect HDM2 inhibition with proliferation arrest, apoptosis, migration, and radiation response. The workflow emphasizes time-resolved and orthogonal measurements so researchers can distinguish reduced growth from true cell killing.
-
FNPs for Stable Lung-Specific mRNA Delivery
2026-08-11
Cao and colleagues developed five-element nanoparticles that combine helper-polymer poly(β-amino esters) with DOTAP to improve lung-directed mRNA delivery and formulation stability. The study identified polymer features associated with stronger performance and reported that lyophilized formulations remained stable at 4 °C for at least six months, offering a practical framework for reducing cold-chain dependence.
-
EZ Cap™ Firefly Luciferase mRNA Workflow Guide
2026-08-10
Learn how to use EZ Cap™ Firefly Luciferase mRNA for quantitative delivery, translation, gene regulation, and imaging workflows. The guide combines practical handling instructions with a formulation-aware framework inspired by recent mRNA-LNP immunogenicity research.